<< NCD to release report on workforce infrastructure for people with disabilities | Maryland seafood processor to stop fish distribution for non-compliance of food safety laws >>

SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnostics

Published on January 9, 2010 at 5:04 AM · No Comments

SeraCare Life Sciences, Inc. (NASDAQ: SRLS) announced today that the Company has added five new, differentiated products to its portfolio to meet the needs of SeraCare’s growing customer base in the life sciences industry.

Susan Vogt, President and Chief Executive Officer stated, “SeraCare ended 2009 with more than 250 new customers across the life sciences industry worldwide and we are pleased to kick off 2010 with the introduction of a variety of products specifically designed to meet the needs of our expanding customer base. The latest additions to our product portfolio continue to set SeraCare apart as a leading provider of high quality products and services that facilitate the discovery, development and manufacturing of drugs and diagnostics.”

SeraCare’s new products include:

Continued on Next page >>

Seventh Sense Biosystems receives Edison Gold Medal Award for Touch Activated Phlebotomy technologySeventh Sense Biosystems, Inc., an early stage, venture-backed company developing a new generation o...
Proteacel acquires exclusive rights to PORE technology from Moffitt Cancer CenterMoffitt Cancer Center and Proteacel LLC announced today that they have entered a licensing agreement...
China Nepstar Chain Drugstore reports revenues of US$91 million for fourth-quarter 2009China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number ...
SeraCare Life Sciences launches new products to aid discovery and development of drugs and diagnosticsSeraCare Life Sciences, Inc. announced today that the Company has added five new, differentiated pro...
Initiation of multi-national Phase III study of Stimuvax announcedMerck KGaA, Darmstadt, Germany, today announced the initiation of its multi-national Phase III study...
Cytokines lead to neurological and cognitive abnormalities and changes in heart rhythm in patients with cirrhosisLiver cirrhosis is the seventh leading cause of death in the United States, taking 25,000 lives per ...
Cell death suppression increases efficacy of M2 vaccinesSignificant public attention has recently been focused on the development of new anti-influenza (flu...
Gene p53 thought to assist chemotherapy may help cancer thriveA gene thought to be essential in helping chemotherapy kill cancer cells, may actually help them thr...
Researchers identify human genes targeted by a virus believed to cause Kaposi's sarcomaUniversity of Florida researchers have identified specific human genes targeted by a virus believed ...
New testing approach to predict outcome in patients with bladder cancerA new testing approach has been shown to be effective in identifying patients at the highest risk of...
Potential biomarker that could be used to predict who might develop hepatic fibrosisTwo new studies on Hepatitis C (HCV) patients who underwent liver transplants examined a potential b...
Correlation between HCV viral load and severity of liver diseaseThe significance of hepatitis C virus (HCV) serum titers (HCV viral load) has been examined in sever...

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Quirky Comment Title
Name*
E-mail*
Country Country flag

b i u quote

Comment
Preview

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.